Free Trial

Millendo Therapeutics (MLND) News Today

Notice: This company has been marked as potentially delisted and may not be actively trading.
Maxim Group Maintains Their Buy Rating on Mind Medicine (MMED)
Expert Ratings for Decibel Therapeutics
Clearmind Announces Pre-IND Meeting Date with FDA
Get Millendo Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for MLND and its competitors with MarketBeat's FREE daily newsletter.

Nvidia’s Quiet $1 Trillion Pivot (Ad)

Nvidia recently added $277 billion in market cap … IN ONE DAY.

Find out details on these three critical Nvidia partners immediately.

MLND Media Mentions By Week

MLND Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

MLND
News Sentiment

0.00

0.74

Average
Medical
News Sentiment

MLND News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

MLND Articles
This Week

0

0

MLND Articles
Average Week

Get Millendo Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for MLND and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:MLND) was last updated on 6/11/2024 by MarketBeat.com Staff

From Our Partners